Table of Contents
Volume 4 | Issue 6
Publication Date: May 2003
Abstract
No Access
Pay-Per View
Full Text
Add to Cart
Editorial | ||
 330 |
Gefitinib for Non–Small-Cell Lung Cancer: Is the Efficacy Real? Chandra P. Belani |
|
Meeting Highlights | ||
333-335 |
Highlights From: 14th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, Frankfurt, Germany Mary Hightower, Jennifer Klem, Mark Socinski, Chandra P. Belani, Vinay K. Jain |
|
Research in Brief | ||
336-338 |
Erlotinib (OSI-774, Tarceva™), a Selective Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Combination with Chemotherapy for Advanced Non–Small-Cell Lung Cancer Mary Hightower, Chandra P. Belani, Vinay K. Jain |
|
Comprehensive Review | ||
339-346 |
Radiation Dose Intensification in Limited-Stage Small-Cell Lung Cancer Kevin S. Roof, Panos Fidias, Thomas J. Lynch, Noah C. Choi |
|
Original Contribution | ||
347-355 |
Gefitinib in the Treatment of Advanced, Refractory Non–Small-Cell Lung Cancer: Results in 124 Patients John D. Hainsworth, Mark G. Mainwaring, Melodie Thomas, Lester L. Porter III, Victor G. Gian, Suzanne F. Jones, F. Anthony Greco |
|
Translational Medicine | ||
356-365 |
Role of Cyclooxygenase-2 Inhibitors in Combination with Radiation Therapy in Lung Cancer Zhongxing Liao, Ritsuko Komaki, Kathryn A. Mason, Luka Milas |
|
Investigative Report | ||
366-369 |
Dermatologic Side Effects Associated with Gefitinib Therapy: Clinical Experience and Management Roy S. Herbst, Patricia M. LoRusso, Michele Purdom, Deborah Ward |
|
